Fiskin, Evgenij
Lareau, Caleb A.
Ludwig, Leif S. http://orcid.org/0000-0002-2916-2164
Eraslan, Gökcen http://orcid.org/0000-0001-9579-2909
Liu, Feimei
Ring, Aaron M. http://orcid.org/0000-0003-3699-2446
Xavier, Ramnik J.
Regev, Aviv http://orcid.org/0000-0003-3293-3158
Article History
Received: 12 September 2020
Accepted: 18 August 2021
First Online: 21 October 2021
Competing interests
: A.R. is a founder and equity holder of Celsius Therapeutics, an equity holder in Immunitas Therapeutics and, until 31 August 2020, was an SAB member of Syros Pharmaceuticals, Neogene Therapeutics, Asimov and Thermo Fisher Scientific. From 1 August 2020, A.R. has been an employee of Genentech. A.M.R. and F.L. are inventors of a patent describing the CEACAM nanobody sequence (US provisional patent 63/068,586). The Broad Institute has filed for a patent related to PHAGE-ATAC where E.F. and A.R. are the named inventors. The remaining authors declare no competing interests.
Free to read: This content has been made available to all.